Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19
- PMID: 32440978
- PMCID: PMC7240164
- DOI: 10.1007/s10072-020-04457-8
Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19
Conflict of interest statement
The authors declare that they have no conflict of interest.
References
-
- Guidon AC, Amato AA (2020) COVID-19 and neuromuscular disorders [published online ahead of print, 2020 Apr 13]. Neurology. 10.1212/WNL.0000000000009566
-
- Klein BC, Busis NA (2020) COVID-19 is catalyzing the adoption of teleneurology. Neurology. 10.1212/WNL.0000000000009494 - PubMed
-
- Hollander JE, Carr BG (2020) Virtually perfect? Telemedicine for Covid-19. N Engl J Med 382(18):1679–1681. 10.1056/NEJMp2003539 - PubMed
-
- Helleman J, Van Eenennaam R, Kruitwagen ET et al (2020) Telehealth as part of specialized ALS care: feasibility and user experiences with ALS home-monitoring and coaching. Amyotroph Lateral Scler Frontotemporal Degener:1–10 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical